Product Name

  • Name

    Flumazenil

  • EINECS 616-650-9
  • CAS No. 78755-81-4
  • Article Data12
  • CAS DataBase
  • Density 1.39 g/cm3
  • Solubility 128 mg/L in water
  • Melting Point 201-203 °C
  • Formula C15H14FN3O3
  • Boiling Point 528 °C at 760 mmHg
  • Molecular Weight 303.293
  • Flash Point 273.1 °C
  • Transport Information
  • Appearance Colourless crystals
  • Safety 26-27-36/37/39
  • Risk Codes 36/37/38
  • Molecular Structure Molecular Structure of 78755-81-4 (Flumazenil)
  • Hazard Symbols IrritantXi
  • Synonyms Anexate;Flumazepil;Flumazenil [USAN:BAN:INN];Romazicon;Flumazenilum [Latin];Flumazenil (JAN/USP);Romazicon (TN);4H-Imidazo[1,5-a][1,4]benzodiazepine-3- carboxylic acid,8-fluoro-5,6-dihydro-5- methyl-6-oxo-,ethyl ester;Flumazenilo;Lanexat;Ethyl 8-fluoro-5-methyl-5,6-dihydro-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate;4H-Imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylic acid, 8-fluoro-5,6-dihydro-5-methyl-6-oxo-, ethyl ester;Ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate;
  • PSA 64.43000
  • LogP 1.71160

Synthetic route

(E)-(dimethylamino-methyleneamino)-acetic acid ethyl ester
428507-28-2

(E)-(dimethylamino-methyleneamino)-acetic acid ethyl ester

2-chloro-7-fluoro-4-methyl-3,4-dihydrobenzo[e][1,4]diazepin-5-one
193693-31-1

2-chloro-7-fluoro-4-methyl-3,4-dihydrobenzo[e][1,4]diazepin-5-one

flumazenil
78755-81-4

flumazenil

Conditions
ConditionsYield
Stage #1: (E)-(dimethylamino-methyleneamino)-acetic acid ethyl ester With lithium hexamethyldisilazane In tetrahydrofuran at -35℃; for 1.5h;
Stage #2: 2-chloro-7-fluoro-4-methyl-3,4-dihydrobenzo[e][1,4]diazepin-5-one With Dimethyl-p-toluidine In tetrahydrofuran at -40 - -35℃; for 3h;
Stage #3: With acetic acid In tetrahydrofuran for 6h; pH=5 - 7; Heating;
98%
ethyl 2-cyanoacetate
105-56-6

ethyl 2-cyanoacetate

2-chloro-7-fluoro-4-methyl-3,4-dihydrobenzo[e][1,4]diazepin-5-one
193693-31-1

2-chloro-7-fluoro-4-methyl-3,4-dihydrobenzo[e][1,4]diazepin-5-one

flumazenil
78755-81-4

flumazenil

Conditions
ConditionsYield
With N,N-dimethyl-aniline; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 0 - 20℃; for 12h; Reagent/catalyst; Solvent;61.3%
8-amino-5,6-dihydro-5-methyl-6-oxo-4H-imidazol[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester
658075-93-5

8-amino-5,6-dihydro-5-methyl-6-oxo-4H-imidazol[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester

flumazenil
78755-81-4

flumazenil

Conditions
ConditionsYield
With pyridine; hydrogen fluoride; sodium nitrite at 20 - 120℃; for 2.5h;51%
Multi-step reaction with 2 steps
1: BF3*Et2O; t-butyl nitrite / CH2Cl2 / -15 - 5 °C
2: 160 mg / 0.67 h / 130 °C
View Scheme
Ethyl isocyanoacetate
2999-46-4

Ethyl isocyanoacetate

7-fluoro-3,4-dihydro-4-methyl-2H-1,4-benzodiazepine-2,5(1H)-dione
78755-80-3

7-fluoro-3,4-dihydro-4-methyl-2H-1,4-benzodiazepine-2,5(1H)-dione

flumazenil
78755-81-4

flumazenil

Conditions
ConditionsYield
Multistep reaction;
(dimethylamino-methyleneamino)-(7-fluoro-4-methyl-5-oxo-1,3,4,5-tetrahydro-benzo[e][1,4]diazepin-2-ylidene)-acetic acid ethyl ester

(dimethylamino-methyleneamino)-(7-fluoro-4-methyl-5-oxo-1,3,4,5-tetrahydro-benzo[e][1,4]diazepin-2-ylidene)-acetic acid ethyl ester

A

flumazenil
78755-81-4

flumazenil

B

(dimethylamino-methyleneamino)-(7-fluoro-4-methyl-5-oxo-1,3,4,5-tetrahydro-benzo[e][1,4]diazepin-2-ylidene)-acetic acid ethyl ester

(dimethylamino-methyleneamino)-(7-fluoro-4-methyl-5-oxo-1,3,4,5-tetrahydro-benzo[e][1,4]diazepin-2-ylidene)-acetic acid ethyl ester

Conditions
ConditionsYield
With acetic acid In tetrahydrofuran pH=5; Heating;
C15H14N5O3(1+)*BF4(1-)

C15H14N5O3(1+)*BF4(1-)

flumazenil
78755-81-4

flumazenil

Conditions
ConditionsYield
at 130℃; for 0.666667h; Balz-Schiemann reaction;160 mg
Ethyl isocyanoacetate
2999-46-4

Ethyl isocyanoacetate

flumazenil
78755-81-4

flumazenil

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1.79 g / sodium hydride / dimethylformamide; tetrahydrofuran / 18 h
2: 97 percent / H2 / Pd/C / tetrahydrofuran; ethanol / 2 h
3: BF3*Et2O; t-butyl nitrite / CH2Cl2 / -15 - 5 °C
4: 160 mg / 0.67 h / 130 °C
View Scheme
Multi-step reaction with 3 steps
1: N-methyl-acetamide; water; acetic acid; ethyl acetate
2: potassium carbonate / ethanol; water; trifluoroacetic acid
3: N-methyl-acetamide; water
View Scheme
7-nitro-3,4-dihydro-4-methyl-2H-1,4-benzodiazepine-2,5-(1H)-dione
84377-96-8

7-nitro-3,4-dihydro-4-methyl-2H-1,4-benzodiazepine-2,5-(1H)-dione

flumazenil
78755-81-4

flumazenil

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: sodium hydride; diethyl chlorophosphate / tetrahydrofuran; dimethylformamide / 0.5 h / 0 °C
2: 1.79 g / sodium hydride / dimethylformamide; tetrahydrofuran / 18 h
3: 97 percent / H2 / Pd/C / tetrahydrofuran; ethanol / 2 h
4: BF3*Et2O; t-butyl nitrite / CH2Cl2 / -15 - 5 °C
5: 160 mg / 0.67 h / 130 °C
View Scheme
8-nitro-5,6-dihydro-5-methyl-6-oxo-4H-imidazol[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester
84377-97-9

8-nitro-5,6-dihydro-5-methyl-6-oxo-4H-imidazol[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester

flumazenil
78755-81-4

flumazenil

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 97 percent / H2 / Pd/C / tetrahydrofuran; ethanol / 2 h
2: BF3*Et2O; t-butyl nitrite / CH2Cl2 / -15 - 5 °C
3: 160 mg / 0.67 h / 130 °C
View Scheme
2-chloro-4-methyl-7-nitro-3,4-dihydro-benzo[e][1,4]diazepin-5-one

2-chloro-4-methyl-7-nitro-3,4-dihydro-benzo[e][1,4]diazepin-5-one

flumazenil
78755-81-4

flumazenil

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1.79 g / sodium hydride / dimethylformamide; tetrahydrofuran / 18 h
2: 97 percent / H2 / Pd/C / tetrahydrofuran; ethanol / 2 h
3: BF3*Et2O; t-butyl nitrite / CH2Cl2 / -15 - 5 °C
4: 160 mg / 0.67 h / 130 °C
View Scheme
7-fluoro-3,4-dihydro-4-methyl-2H-1,4-benzodiazepine-2,5(1H)-dione
78755-80-3

7-fluoro-3,4-dihydro-4-methyl-2H-1,4-benzodiazepine-2,5(1H)-dione

flumazenil
78755-81-4

flumazenil

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: 86 percent / phosphorus oxychloride; N,N-dimethyl-p-toluidine / toluene / 2 h / 100 °C
2.1: LHMDS / tetrahydrofuran / 1.5 h / -35 °C
2.2: N,N-dimethyl-p-toluidine / tetrahydrofuran / 3 h / -40 - -35 °C
2.3: 98 percent / acetic acid / tetrahydrofuran / 6 h / pH 5 - 7 / Heating
View Scheme
Multi-step reaction with 3 steps
1.1: 86 percent / phosphorus oxychloride; N,N-dimethyl-p-toluidine / toluene / 2 h / 100 °C
2.1: LHMDS / tetrahydrofuran / 2 h / -30 °C
2.2: N,N-dimethyl-p-toluidine / tetrahydrofuran / -35 °C / pH 7
3.1: acetic acid / tetrahydrofuran / pH 5 / Heating
View Scheme
(E)-(dimethylamino-methyleneamino)-acetic acid ethyl ester
428507-28-2

(E)-(dimethylamino-methyleneamino)-acetic acid ethyl ester

flumazenil
78755-81-4

flumazenil

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: LHMDS / tetrahydrofuran / 2 h / -30 °C
1.2: N,N-dimethyl-p-toluidine / tetrahydrofuran / -35 °C / pH 7
2.1: acetic acid / tetrahydrofuran / pH 5 / Heating
View Scheme
2-chloro-7-fluoro-4-methyl-3,4-dihydrobenzo[e][1,4]diazepin-5-one
193693-31-1

2-chloro-7-fluoro-4-methyl-3,4-dihydrobenzo[e][1,4]diazepin-5-one

flumazenil
78755-81-4

flumazenil

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: LHMDS / tetrahydrofuran / 2 h / -30 °C
1.2: N,N-dimethyl-p-toluidine / tetrahydrofuran / -35 °C / pH 7
2.1: acetic acid / tetrahydrofuran / pH 5 / Heating
View Scheme
1,1,1,3,3,3-hexamethyl-disilazane
999-97-3

1,1,1,3,3,3-hexamethyl-disilazane

Dimethyl-p-toluidine
99-97-8

Dimethyl-p-toluidine

(E)-(dimethylamino-methyleneamino)-acetic acid ethyl ester
428507-28-2

(E)-(dimethylamino-methyleneamino)-acetic acid ethyl ester

2-chloro-7-fluoro-4-methyl-3,4-dihydrobenzo[e][1,4]diazepin-5-one
193693-31-1

2-chloro-7-fluoro-4-methyl-3,4-dihydrobenzo[e][1,4]diazepin-5-one

flumazenil
78755-81-4

flumazenil

Conditions
ConditionsYield
With n-butyllithium; sodium hydrogencarbonate; acetic acid In tetrahydrofuran; ethanol; n-heptane; dichloromethane
ethyl N-<(dimethylamino)methylene>glycinate
30766-78-0

ethyl N-<(dimethylamino)methylene>glycinate

1,1,1,3,3,3-hexamethyl-disilazane
999-97-3

1,1,1,3,3,3-hexamethyl-disilazane

Dimethyl-p-toluidine
99-97-8

Dimethyl-p-toluidine

2-chloro-7-fluoro-4-methyl-3,4-dihydrobenzo[e][1,4]diazepin-5-one
193693-31-1

2-chloro-7-fluoro-4-methyl-3,4-dihydrobenzo[e][1,4]diazepin-5-one

flumazenil
78755-81-4

flumazenil

Conditions
ConditionsYield
With n-butyllithium; sodium hydrogencarbonate; acetic acid In tetrahydrofuran; n-heptane; dichloromethane
Ethyl isocyanoacetate
2999-46-4

Ethyl isocyanoacetate

potassium tert-butylate
865-47-4

potassium tert-butylate

diethyl chlorophosphate
814-49-3

diethyl chlorophosphate

7-fluoro-3,4-dihydro-4-methyl-2H-1,4-benzodiazepine-2,5(1H)-dione
78755-80-3

7-fluoro-3,4-dihydro-4-methyl-2H-1,4-benzodiazepine-2,5(1H)-dione

flumazenil
78755-81-4

flumazenil

Conditions
ConditionsYield
In N-methyl-acetamide; water; acetic acid
dichloroamine
3400-09-7

dichloroamine

Ethyl isocyanoacetate
2999-46-4

Ethyl isocyanoacetate

potassium tert-butylate
865-47-4

potassium tert-butylate

7-fluoro-3,4-dihydro-4-methyl-2H-1,4-benzodiazepine-2,5(1H)-dione
78755-80-3

7-fluoro-3,4-dihydro-4-methyl-2H-1,4-benzodiazepine-2,5(1H)-dione

flumazenil
78755-81-4

flumazenil

Conditions
ConditionsYield
With sodium hydrogencarbonate; acetic acid; trichlorophosphate In N-methyl-acetamide; chloroform; water; 2,3-Dimethylaniline
ethyl 8-fluoro-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate
79089-72-8

ethyl 8-fluoro-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate

flumazenil
78755-81-4

flumazenil

Conditions
ConditionsYield
In N-methyl-acetamide; water
Ethyl isocyanoacetate
2999-46-4

Ethyl isocyanoacetate

C14H18FN2O5P

C14H18FN2O5P

flumazenil
78755-81-4

flumazenil

Conditions
ConditionsYield
With potassium tert-butylate In tetrahydrofuran at -35 - 20℃; Inert atmosphere;2 g
(3-(ethoxycarbonyl)-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepin-8-yl)(4-methylphenyl)iodonium tosylate
1350523-27-1

(3-(ethoxycarbonyl)-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepin-8-yl)(4-methylphenyl)iodonium tosylate

A

ethyl 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][ 1,4]benzodiazepine-3-carboxylate
78756-03-3

ethyl 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][ 1,4]benzodiazepine-3-carboxylate

B

flumazenil
78755-81-4

flumazenil

C

Ro 41-8157
268566-09-2

Ro 41-8157

Conditions
ConditionsYield
With 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; cesium fluoride In N,N-dimethyl-formamide; acetonitrile at 90℃; for 2h;
(3-(ethoxycarbonyl)-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepin-8-yl)(phenyl)iodonium tosylate
1350523-17-9

(3-(ethoxycarbonyl)-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepin-8-yl)(phenyl)iodonium tosylate

A

ethyl 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][ 1,4]benzodiazepine-3-carboxylate
78756-03-3

ethyl 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][ 1,4]benzodiazepine-3-carboxylate

B

flumazenil
78755-81-4

flumazenil

C

Ro 41-8157
268566-09-2

Ro 41-8157

Conditions
ConditionsYield
With 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; cesium fluoride In N,N-dimethyl-formamide; acetonitrile at 90℃; for 2h;
(3-(ethoxycarbonyl)-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepin-8-yl)(2-thiophenyl)iodonium tosylate
1350523-19-1

(3-(ethoxycarbonyl)-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepin-8-yl)(2-thiophenyl)iodonium tosylate

A

ethyl 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][ 1,4]benzodiazepine-3-carboxylate
78756-03-3

ethyl 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][ 1,4]benzodiazepine-3-carboxylate

B

flumazenil
78755-81-4

flumazenil

C

Ro 41-8157
268566-09-2

Ro 41-8157

Conditions
ConditionsYield
With 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; cesium fluoride In N,N-dimethyl-formamide; acetonitrile at 90℃; for 2h;
(3-(ethoxycarbonyl)-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepin-8-yl)(3-thiophenyl)iodonium tosylate
1350523-21-5

(3-(ethoxycarbonyl)-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepin-8-yl)(3-thiophenyl)iodonium tosylate

A

ethyl 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][ 1,4]benzodiazepine-3-carboxylate
78756-03-3

ethyl 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][ 1,4]benzodiazepine-3-carboxylate

B

flumazenil
78755-81-4

flumazenil

C

Ro 41-8157
268566-09-2

Ro 41-8157

Conditions
ConditionsYield
With 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; cesium fluoride In N,N-dimethyl-formamide; acetonitrile at 90℃; for 2h;
(3-(ethoxycarbonyl)-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepin-8-yl)(4-methoxyphenyl)iodonium tosylate
1350523-23-7

(3-(ethoxycarbonyl)-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepin-8-yl)(4-methoxyphenyl)iodonium tosylate

A

ethyl 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][ 1,4]benzodiazepine-3-carboxylate
78756-03-3

ethyl 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][ 1,4]benzodiazepine-3-carboxylate

B

flumazenil
78755-81-4

flumazenil

C

Ro 41-8157
268566-09-2

Ro 41-8157

Conditions
ConditionsYield
With 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; cesium fluoride In N,N-dimethyl-formamide; acetonitrile at 90℃; for 2h;
(3-(ethoxycarbonyl)-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepin-8-yl)(3-methoxyphenyl)iodonium tosylate
1350523-25-9

(3-(ethoxycarbonyl)-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepin-8-yl)(3-methoxyphenyl)iodonium tosylate

A

ethyl 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][ 1,4]benzodiazepine-3-carboxylate
78756-03-3

ethyl 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][ 1,4]benzodiazepine-3-carboxylate

B

flumazenil
78755-81-4

flumazenil

C

Ro 41-8157
268566-09-2

Ro 41-8157

Conditions
ConditionsYield
With 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; cesium fluoride In N,N-dimethyl-formamide; acetonitrile at 90℃; for 2h;
ethyl 5,6-dihydro-5-methyl-6-oxo-8-tributylstannyl-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
200408-05-5

ethyl 5,6-dihydro-5-methyl-6-oxo-8-tributylstannyl-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate

A

ethyl 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][ 1,4]benzodiazepine-3-carboxylate
78756-03-3

ethyl 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][ 1,4]benzodiazepine-3-carboxylate

B

flumazenil
78755-81-4

flumazenil

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dichloromethane; acetonitrile / 20 h / 20 °C / Inert atmosphere
2: 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; cesium fluoride / N,N-dimethyl-formamide; acetonitrile / 2 h / 90 °C
View Scheme
Multi-step reaction with 2 steps
1: dichloromethane; acetonitrile / 20 h / 20 °C / Inert atmosphere
2: 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; cesium fluoride / N,N-dimethyl-formamide; acetonitrile / 2 h / 90 °C
View Scheme
Multi-step reaction with 2 steps
1: dichloromethane; acetonitrile / 20 h / 20 °C / Inert atmosphere
2: 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; cesium fluoride / N,N-dimethyl-formamide; acetonitrile / 2 h / 90 °C
View Scheme
4-(2,4-dimethoxybenzyl)-7-fluoro-3,4-dihydro-2H-1,4-benzodiazepine-2,5(1H)-dione

4-(2,4-dimethoxybenzyl)-7-fluoro-3,4-dihydro-2H-1,4-benzodiazepine-2,5(1H)-dione

flumazenil
78755-81-4

flumazenil

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: N-methyl-acetamide; water; acetic acid; ethyl acetate
2: potassium carbonate / ethanol; water; trifluoroacetic acid
3: N-methyl-acetamide; water
View Scheme
ethyl 5-(2,4-dimethoxybenzyl)-8-fluoro-5,6-dihydro-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate

ethyl 5-(2,4-dimethoxybenzyl)-8-fluoro-5,6-dihydro-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate

flumazenil
78755-81-4

flumazenil

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: potassium carbonate / ethanol; water; trifluoroacetic acid
2: N-methyl-acetamide; water
View Scheme
flumazenil
78755-81-4

flumazenil

8-Fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid
84378-44-9

8-Fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid

Conditions
ConditionsYield
Stage #1: flumazenil With sodium hydroxide In tetrahydrofuran; water at 20℃;
Stage #2: With hydrogenchloride In water
100%
With tetra(n-butyl)ammonium hydroxide; water Hydrolysis;
flumazenil
78755-81-4

flumazenil

C15H13(2)HFN3O3

C15H13(2)HFN3O3

Conditions
ConditionsYield
With [(N,N′-bis(2,6-diisopropylphenyl)-2,3-butanediimine)Ni(μ−H)]2; deuterium In tetrahydrofuran at -196 - 45℃; under 760.051 Torr; for 24h; Reagent/catalyst; Sealed tube;100%
With ethyl [2]alcohol; di(tertbutyl)phenylphosphine; silver carbonate In dichloromethane at 50 - 80℃; Inert atmosphere;69%
flumazenil
78755-81-4

flumazenil

C15H10(2)H4FN3O3

C15H10(2)H4FN3O3

Conditions
ConditionsYield
With [(N,N’-bis(1R,2R,3R,5S)-(−)-isopinocampheyl-1,2-ethanediimine-radical)NiI(μ2-H)]2; deuterium In tetrahydrofuran at -196 - 45℃; under 760.051 Torr; for 24h; Reagent/catalyst; Sealed tube;98%
flumazenil
78755-81-4

flumazenil

ethyl 6-cyano-8-fluoro-5-methyl-5,6-dihydro-4Hbenzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate

ethyl 6-cyano-8-fluoro-5-methyl-5,6-dihydro-4Hbenzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate

Conditions
ConditionsYield
Stage #1: flumazenil With bis(triphenylphosphine)iridium(I) carbonyl chloride In toluene at 20℃; for 0.0833333h;
Stage #2: With 1,1,3,3-Tetramethyldisiloxane In toluene at 20℃; for 0.0833333h;
Stage #3: With trimethylsilyl cyanide In toluene at 20℃; for 0.5h;
47%
isobutyramide oxime
35613-84-4

isobutyramide oxime

flumazenil
78755-81-4

flumazenil

8-Fluoro-3-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-5-methyl-4,5-dihydro-2,5,10b-triaza-benzo[e]azulen-6-one

8-Fluoro-3-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-5-methyl-4,5-dihydro-2,5,10b-triaza-benzo[e]azulen-6-one

Conditions
ConditionsYield
With molecular sieve; sodium hydride 1) THF, r.t., 2) THF, reflux; Yield given. Multistep reaction;
flumazenil
78755-81-4

flumazenil

8-fluoro-5,6-dihydro-5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-4H-imidazo[1,5-a][1,4]benzodiazepin-6-one

8-fluoro-5,6-dihydro-5-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-4H-imidazo[1,5-a][1,4]benzodiazepin-6-one

Conditions
ConditionsYield
With molecular sieve; sodium hydride 1) THF, r.t., 2) THF, reflux; Yield given. Multistep reaction;
flumazenil
78755-81-4

flumazenil

N-hydroxypropanimidamide
29335-36-2

N-hydroxypropanimidamide

FG 8006

FG 8006

Conditions
ConditionsYield
With molecular sieve; sodium hydride 1) THF, r.t., 2) THF, reflux; Yield given. Multistep reaction;
flumazenil
78755-81-4

flumazenil

butyramide oxime
27620-10-6

butyramide oxime

8-Fluoro-5-methyl-3-(3-propyl-[1,2,4]oxadiazol-5-yl)-4,5-dihydro-2,5,10b-triaza-benzo[e]azulen-6-one

8-Fluoro-5-methyl-3-(3-propyl-[1,2,4]oxadiazol-5-yl)-4,5-dihydro-2,5,10b-triaza-benzo[e]azulen-6-one

Conditions
ConditionsYield
With molecular sieve; sodium hydride 1) THF, r.t., 2) THF, reflux; Yield given. Multistep reaction;
flumazenil
78755-81-4

flumazenil

[18F]flumanezil

[18F]flumanezil

Conditions
ConditionsYield
With 2,4,6-trimethyl-pyridine; potassium hydrogencarbonate In water; acetonitrile at 160℃; under 375.03 Torr;
With potassium carbonate; [2.2.2]cryptande; [18F]fluoride ion, cyclotron produced, NCA In dimethyl sulfoxide at 130℃;
flumazenil
78755-81-4

flumazenil

2-[(p-toluenesulfonyl)oxy]ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
676437-17-5

2-[(p-toluenesulfonyl)oxy]ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: tetrabutylammonium hydroxide; water
2: 63 percent / tetrabutylammonium hydroxide / CH2Cl2
View Scheme
flumazenil
78755-81-4

flumazenil

isopropyl alcohol
67-63-0

isopropyl alcohol

isopropyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate

isopropyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate

flumazenil
78755-81-4

flumazenil

ethylene glycol
107-21-1

ethylene glycol

(2-hydroxyethyl) 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate

(2-hydroxyethyl) 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate

Conditions
ConditionsYield
In chloroform; ethyl acetate

Flumazenil Specification

Flumazenil, with the CAS NO.78755-81-4, has the IUPAC Name of Ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate. Synonyms of it are 4H-Imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylic acid, 8-fluoro-5,6-dihydro-5-methyl-6-oxo-, ethyl ester; 4H-Imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid, 8-fluoro-5,6-dihydro-5-methyl-6-oxo-, ethyl ester; 8-Fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester; 8-Fluoro-5-méthyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazépine-3-carboxylate d'éthyle. It is a benzodiazepine receptor antagonist available for injection only, and the only benzodiazepine receptor antagonist on the market today.

Physical properties about Flumazenil are: (1)ACD/LogP: 2.151; (2)ACD/LogD (pH 5.5): 2.15; (3)ACD/LogD (pH 7.4): 2.15; (4)ACD/BCF (pH 5.5): 25.41; (5)ACD/BCF (pH 7.4): 25.41; (6)ACD/KOC (pH 5.5): 352.59; (7)ACD/KOC (pH 7.4): 352.60; (8)#H bond acceptors: 6; (9)#Freely Rotating Bonds: 3; (10)Index of Refraction: 1.634 ; (11)Molar Refractivity: 77.586 cm3; (12)Molar Volume: 217.075 cm3; (13)Polarizability: 30.757 10-24cm3; (14)Surface Tension: 48.4690017700195 dyne/cm; (15)Density: 1.397 g/cm3; (16)Flash Point: 273.115 °C; (17)Enthalpy of Vaporization: 80.269 kJ/mol; (18)Boiling Point: 527.983 °C at 760 mmHg

Uses of Flumazenil: Flumazenil is used to against the sedative effect and disorientation after use of overdose of benzodiazepine drugs leather, and has anticonvulsant activity and antiepileptic effect. It can also be used after the recovery period and encephalopathy due to cirrhosis of the liver due to alcoholism, unexplained loss of consciousness diagnostic medicine. Besides it is also used to identify the benzodiazepine class and other drug intoxication or brain damage. It is still used as central nervous system stimulant.

When you are using this chemical, please be cautious about it as the following:
1. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice;
2. Take off immediately all contaminated clothing;
3. Wear suitable protective clothing, gloves and eye/face protection;

You can still convert the following datas into molecular structure:
(1)InChI=1S/C15H14FN3O3/c1-3-22-15(21)13-12-7-18(2)14(20)10-6-9(16)4-5-11(10)19(12)8-17-13/h4-6,8H,3,7H2,1-2H3;
(2)InChIKey=OFBIFZUFASYYRE-UHFFFAOYSA-N;
(3)Smilesn12c3c(C(=O)N(Cc1c(nc2)C(=O)OCC)C)cc(cc3)F

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LDLo intravenous > 30mg/kg (30mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 23, Pg. 201, 1992.
dog LDLo oral > 640mg/kg (640mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 23, Pg. 201, 1992.
man LDLo intravenous 5700ng/kg/C (.0057mg/kg) CARDIAC: CARDIOMYOPATHY INCLUDING INFARCTION

CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION)

CARDIAC: CHANGE IN RATE
British Medical Journal. Vol. 304, Pg. 1415, 1992.
mouse LD50 intraperitoneal 4gm/kg (4000mg/kg)   Drugs of the Future. Vol. 7, Pg. 402, 1982.
mouse LD50 intravenous 143mg/kg (143mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: REGIDITY
Journal de Toxicologie Clinique et Experimentale. Vol. 7, Pg. 223, 1987.
mouse LD50 oral 1300mg/kg (1300mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: REGIDITY

BEHAVIORAL: TREMOR
Journal de Toxicologie Clinique et Experimentale. Vol. 7, Pg. 223, 1987.
mouse LDLo subcutaneous > 1gm/kg (1000mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 23, Pg. 201, 1992.
rabbit LD50 oral 2gm/kg (2000mg/kg) BEHAVIORAL: TREMOR

BEHAVIORAL: REGIDITY

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Journal de Toxicologie Clinique et Experimentale. Vol. 7, Pg. 223, 1987.
rat LD50 intraperitoneal 1360mg/kg (1360mg/kg)   Drugs of the Future. Vol. 7, Pg. 402, 1982.
rat LD50 intravenous 85mg/kg (85mg/kg) BEHAVIORAL: REGIDITY

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Journal de Toxicologie Clinique et Experimentale. Vol. 7, Pg. 223, 1987.
rat LD50 oral 4200mg/kg (4200mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: REGIDITY

BEHAVIORAL: TREMOR
Journal de Toxicologie Clinique et Experimentale. Vol. 7, Pg. 223, 1987.
women TDLo intravenous 4ug/kg (.004mg/kg) CARDIAC: EKG CHANGES NOT DIAGNOSTIC OF ABOVE

CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Pediatric Emergency Care. Vol. 11, Pg. 186, 1995.
women TDLo oral 2mg/kg/2D-I (2mg/kg) BEHAVIORAL: EXCITEMENT

BEHAVIORAL: AGGRESSION

BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"
Lancet. Vol. 339, Pg. 488, 1992.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View